Posterior Segment Bioavailability
Posterior Segment Bioavailability is the bioavailability of ophthalmic drugs specifically within the posterior segment of the eye, distinguished from anterior segment bioavailability by its focus on the vitreous humor, retina, and choroid, where drug delivery is hindered by ocular barriers and systemic absorption.
5
Publications
459
Citations
32
Authors
9
Institutions
Publications per year
2017–2026
1
Parents
5
Drug delivery for posterior segment eye disease.
Dayle H. Geroski, H. F. Edelhauser · PubMed · 2000 · 342 citations
Hydrogel Ring for Topical Drug Delivery to the Ocular Posterior Segment
Yuko Shikamura, Yoshiko Yamazaki, Toru Matsunaga et al. · Current Eye Research · 2015 · 37 citations
1–5 of 5
32
1
h-index
1
h-index
1
h-index
1
h-index
1
h-index
1–5 of 32
9
Emory Eye Center
Atlanta, United States
1 h-index
2 publications
684 citations
Kyushu Institute of Technology
Kitakyushu, Japan
1 h-index
2 publications
74 citations
Henan Provincial Eye Hospital
Zhengzhou, China
1 h-index
8 publications
136 citations

Zhengzhou University
Zhengzhou, China
1 h-index
8 publications
136 citations
Senju Pharmaceutical (Japan)
Osaka, Japan
1 h-index
2 publications
74 citations

University of the Witwatersrand
Johannesburg, South Africa
1 h-index
7 publications
77 citations
Henan Provincial People's Hospital
Zhengzhou, China
1 h-index
8 publications
136 citations
Alcon (United States)
Fort Worth, United States
1 h-index
6 publications
312 citations
1–8 of 9
1 publications · 17 citations
1
h-index
Repository · 1 publications · 342 citations
1
h-index
1 publications · 52 citations
1
h-index
1 publications · 37 citations
1
h-index
1 publications · 11 citations
1
h-index
1–5